File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1159/000187576
- Scopus: eid_2-s2.0-0027377785
- PMID: 8302422
- WOS: WOS:A1993MJ67200022
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Resolution of membranoproliferative glomerulonephritis complicating angiofollicular lymph node hyperplasia (Castleman's Disease)
Title | Resolution of membranoproliferative glomerulonephritis complicating angiofollicular lymph node hyperplasia (Castleman's Disease) |
---|---|
Authors | |
Keywords | Angiofollicular lymph node hyperplasia Castleman's disease Membranoproliferative glomerulonephritis |
Issue Date | 1993 |
Publisher | S Karger AG. The Journal's web site is located at http://www.karger.com/NEF |
Citation | Nephron, 1993, v. 65 n. 4, p. 628-632 How to Cite? |
Abstract | A novel renal complication was reported in a patient with angiofollicular lymph node hyperplasia (Castleman's Disease), who developed acute renal failure due to membranoproliferative glomerulonephritis. Renal biopsy showed marked mesangial hyperplasia, basement membrane thickening with subendothelial electron-dense deposits, interstitial plasma cell infiltration, and glomerular deposition of IgM and complement components. A resolution of systemic manifestations and an improvement in renal function followed prednisolone and azathioprine therapy. Disease relapse, with increasing proteinuria and the development of factor 8 inhibitor, occurred 3 months later. Sustained remission was achieved with prednisolone and cyclophosphamide therapy, which were given for 42 and 12 months, respectively. Renal biopsy during remission showed significant resolution of the mesangial hyperplasia and disappearance of interstitial plasmacytic infiltration as well as subendothelial electron-dense deposits. |
Persistent Identifier | http://hdl.handle.net/10722/147969 |
ISSN | 2023 SCImago Journal Rankings: 0.774 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chan, TM | en_HK |
dc.contributor.author | Cheng, IKP | en_HK |
dc.contributor.author | Wong, KL | en_HK |
dc.contributor.author | Chan, KW | en_HK |
dc.date.accessioned | 2012-05-29T06:10:09Z | - |
dc.date.available | 2012-05-29T06:10:09Z | - |
dc.date.issued | 1993 | en_HK |
dc.identifier.citation | Nephron, 1993, v. 65 n. 4, p. 628-632 | en_HK |
dc.identifier.issn | 0028-2766 | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/147969 | - |
dc.description.abstract | A novel renal complication was reported in a patient with angiofollicular lymph node hyperplasia (Castleman's Disease), who developed acute renal failure due to membranoproliferative glomerulonephritis. Renal biopsy showed marked mesangial hyperplasia, basement membrane thickening with subendothelial electron-dense deposits, interstitial plasma cell infiltration, and glomerular deposition of IgM and complement components. A resolution of systemic manifestations and an improvement in renal function followed prednisolone and azathioprine therapy. Disease relapse, with increasing proteinuria and the development of factor 8 inhibitor, occurred 3 months later. Sustained remission was achieved with prednisolone and cyclophosphamide therapy, which were given for 42 and 12 months, respectively. Renal biopsy during remission showed significant resolution of the mesangial hyperplasia and disappearance of interstitial plasmacytic infiltration as well as subendothelial electron-dense deposits. | en_HK |
dc.language | eng | en_US |
dc.publisher | S Karger AG. The Journal's web site is located at http://www.karger.com/NEF | en_HK |
dc.relation.ispartof | Nephron | en_HK |
dc.subject | Angiofollicular lymph node hyperplasia | en_HK |
dc.subject | Castleman's disease | en_HK |
dc.subject | Membranoproliferative glomerulonephritis | en_HK |
dc.subject.mesh | Adult | en_US |
dc.subject.mesh | Azathioprine - Therapeutic Use | en_US |
dc.subject.mesh | Biopsy | en_US |
dc.subject.mesh | Complement System Proteins - Analysis | en_US |
dc.subject.mesh | Cyclophosphamide - Therapeutic Use | en_US |
dc.subject.mesh | Drug Therapy, Combination | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Giant Lymph Node Hyperplasia - Complications - Drug Therapy - Pathology | en_US |
dc.subject.mesh | Glomerulonephritis, Membranoproliferative - Complications - Drug Therapy - Pathology | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Immunoglobulin M - Analysis | en_US |
dc.subject.mesh | Kidney Failure, Chronic - Etiology | en_US |
dc.subject.mesh | Kidney Glomerulus - Chemistry - Pathology | en_US |
dc.subject.mesh | Prednisolone - Therapeutic Use | en_US |
dc.subject.mesh | Prognosis | en_US |
dc.title | Resolution of membranoproliferative glomerulonephritis complicating angiofollicular lymph node hyperplasia (Castleman's Disease) | en_HK |
dc.type | Article | en_HK |
dc.identifier.email | Chan, TM:dtmchan@hku.hk | en_HK |
dc.identifier.email | Chan, KW:hrmtckw@hku.hk | en_HK |
dc.identifier.authority | Chan, TM=rp00394 | en_HK |
dc.identifier.authority | Chan, KW=rp00330 | en_HK |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.doi | 10.1159/000187576 | - |
dc.identifier.pmid | 8302422 | - |
dc.identifier.scopus | eid_2-s2.0-0027377785 | en_HK |
dc.identifier.volume | 65 | en_HK |
dc.identifier.issue | 4 | en_HK |
dc.identifier.spage | 628 | en_HK |
dc.identifier.epage | 632 | en_HK |
dc.identifier.isi | WOS:A1993MJ67200022 | - |
dc.publisher.place | Switzerland | en_HK |
dc.identifier.scopusauthorid | Chan, TM=7402687700 | en_HK |
dc.identifier.scopusauthorid | Cheng, IKP=7102537483 | en_HK |
dc.identifier.scopusauthorid | Wong, KL=7404759833 | en_HK |
dc.identifier.scopusauthorid | Chan, KW=16444133100 | en_HK |
dc.identifier.issnl | 0028-2766 | - |